Completed NA INTERVENTIONAL 2-arm NCT01616082

Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II) (MagellanII)

Effect of Caloric Restriction on Metabolic Biomarkers and Fat Oxidation in Obese Men and Women (Magellan II)

Sponsor: AdventHealth Translational Research Institute

Conditions Metabolic Diseases Obesity Overweight

Interventions Low Calorie Diet (LCD) Phentermine

Updated 9 times since 2017 Last updated: Oct 21, 2020 Started: Sep 30, 2011 Primary completion: Nov 30, 2012 Completion: Nov 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Metabolic Diseases and Obesity and is currently completed. AdventHealth Translational Research Institute leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Mar 2022 — Dec 2022 [monthly]

Completed NA

▶ Show 4 earlier versions

Jan 2021 — Mar 2022 [monthly]

Completed NA
Dec 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Dec 2020 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AdventHealth Translational Research Institute
Takeda

Data source: AdventHealth Translational Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orlando, United States